Position in BIOA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$617,746
+$227,104 QoQ
Shares Held
35,320
+19.6% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 14.54983012457531.ToString("F0")%
Shared 0.ToString("F0")%
None 85.45016987542469.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. BIOA ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,229,009 | $145,281,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
122,486 | $72,631,748 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
303,820 | $40,025,246 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,268,203 | $30,348,097 | |
| 5 | VTRS |
Viatris Inc
|
1,941,082 | $26,224,017 | |
| 6 | ALKS |
Alkermes plc.
|
449,531 | $15,895,416 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
194,563 | $14,757,603 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
643,856 | $13,366,450 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $617,746 | 35,320 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $390,642 | 29,527 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $168,473 | 28,652 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $124,461 | 30,136 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $36,848 | 9,800 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $22,337 | 3,858 | Shares | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||